A carregar...

Safety and efficacy of subcutaneous and continuous intravenous infusion rIL-2 in patients with metastatic renal cell carcinoma

A retrospective analysis was conducted on data from four open-label, nonrandomised, phase II trials of recombinant interleukin-2 (rIL-2) in patients with metastatic renal cell carcinoma to compare the safety and efficacy of administration by subcutaneous (s.c.) and continuous intravenous (c.i.v.) in...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Geertsen, P F, Gore, M E, Negrier, S, Tourani, J M, von der Maase, H
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2004
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2409650/
https://ncbi.nlm.nih.gov/pubmed/15026795
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6601709
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!